Enveric Biosciences Inc (ENVB)
0.98
+0.05
(+5.89%)
USD |
NASDAQ |
May 03, 16:00
0.9616
-0.02
(-1.88%)
Pre-Market: 20:00
Enveric Biosciences Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.99% |
March 31, 2024 | 99.99% |
February 29, 2024 | 99.99% |
January 31, 2024 | 99.99% |
December 31, 2023 | 99.99% |
November 30, 2023 | 99.99% |
October 31, 2023 | 99.99% |
September 30, 2023 | 99.99% |
August 31, 2023 | 99.99% |
July 31, 2023 | 99.99% |
June 30, 2023 | 99.99% |
May 31, 2023 | 99.99% |
April 30, 2023 | 99.99% |
March 31, 2023 | 99.99% |
February 28, 2023 | 99.99% |
January 31, 2023 | 99.99% |
December 31, 2022 | 99.99% |
November 30, 2022 | 99.99% |
October 31, 2022 | 99.99% |
September 30, 2022 | 99.99% |
August 31, 2022 | 99.99% |
July 31, 2022 | 99.99% |
June 30, 2022 | 99.98% |
May 31, 2022 | 99.98% |
April 30, 2022 | 99.97% |
Date | Value |
---|---|
March 31, 2022 | 99.97% |
February 28, 2022 | 99.97% |
January 31, 2022 | 99.93% |
December 31, 2021 | 99.90% |
November 30, 2021 | 99.86% |
October 31, 2021 | 99.82% |
September 30, 2021 | 99.82% |
August 31, 2021 | 99.82% |
July 31, 2021 | 99.79% |
June 30, 2021 | 99.79% |
May 31, 2021 | 99.79% |
April 30, 2021 | 99.76% |
March 31, 2021 | 99.71% |
February 28, 2021 | 99.71% |
January 31, 2021 | 99.71% |
December 31, 2020 | 99.71% |
November 30, 2020 | 99.71% |
October 31, 2020 | 99.71% |
September 30, 2020 | 99.71% |
August 31, 2020 | 99.71% |
July 31, 2020 | 99.71% |
June 30, 2020 | 99.71% |
May 31, 2020 | 99.71% |
April 30, 2020 | 99.71% |
March 31, 2020 | 99.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.13%
Minimum
May 2019
99.99%
Maximum
Nov 2022
99.68%
Average
99.84%
Median
Max Drawdown (5Y) Benchmarks
Seelos Therapeutics Inc | 99.93% |
Societal CDMO Inc (DELISTED) | 98.41% |
Cardiff Oncology Inc | 99.92% |
BioVie Inc | 98.96% |
Adial Pharmaceuticals Inc | 99.30% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -88.84 |
Beta (5Y) | 0.8197 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 111.9% |
Historical Sharpe Ratio (5Y) | -0.7123 |
Historical Sortino (5Y) | -1.753 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.61% |